ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,377Medicare Part D Prescriptions Filled, Including Refills

Rank: 724 out of 3647

$683K Total Retail Price of All Prescriptions

Rank: 595 out of 3647

299 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
84% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 299 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

9% of this provider’s 299 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

1% of this provider’s 8,662 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

38 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
LEVOTHYROXINE SODIUM 525 374 1 5
SIMVASTATIN 456 348 2 1
LISINOPRIL 420 341 3 4
AMLODIPINE BESYLATE 374 310 4 2
NAMENDA 287 287 5 49
FUROSEMIDE 269 204 6 8
POTASSIUM CHLORIDE 244 144 7 24
DONEPEZIL HCL 229 229 8 30
OMEPRAZOLE 228 171 9 3
DIVALPROEX SODIUM 216 140 10 131
WARFARIN SODIUM 212 195 11 15
TRAMADOL HCL 207 155 12 22
METOPROLOL TARTRATE 203 138 13 7
ESCITALOPRAM OXALATE 187 137 14 65
CITALOPRAM HBR 185 153 15 25
RISPERIDONE 176 111 16 83
MIRTAZAPINE 168 151 17 63
GABAPENTIN 127 97 18 17
METFORMIN HCL 126 83 19 6
OXYBUTYNIN CHLORIDE 118 77 20 107
HYDROCODONE-ACETAMINOPHEN 104 51 S3 21 12
FAMOTIDINE 96 96 22 61
QUETIAPINE FUMARATE 87 67 23 89
NOVOLIN R 86 77 24 139
CARBIDOPA-LEVODOPA 85 69 25 127
LACTULOSE 82 30 26 128
CARVEDILOL 81 74 27 20
LEVETIRACETAM 80 21 28 122
OLANZAPINE 79 59 29 240
CYMBALTA 77 51 30 79
LAMOTRIGINE 75 53 31 266
CLOPIDOGREL 74 54 32 26
LOVASTATIN 74 63 32 21
PLAVIX 74 45 32 39
METOPROLOL SUCCINATE 74 54 32 18
SERTRALINE HCL 70 53 36 27
BUMETANIDE 67 42 37 134
RAMIPRIL 65 53 38 101
ABILIFY 65 64 38 205
ALENDRONATE SODIUM 64 62 40 23
ZOLPIDEM TARTRATE 63 44 41 14
OXYBUTYNIN CHLORIDE ER 63 51 41 169
SEROQUEL XR 63 43 41 252
HYDROCHLOROTHIAZIDE 62 44 44 9
LEXAPRO 60 41 45 177
BENZTROPINE MESYLATE 59 19 R 46 222
SINGULAIR 56 33 47 90
ATENOLOL 55 49 48 10
LANTUS 55 42 48 59
FLUTICASONE PROPIONATE 54 45 50 32
LIDODERM 54 53 50 108
TAMSULOSIN HCL 53 47 52 28
CLONIDINE HCL 50 38 53 46
BUSPIRONE HCL 50 42 53 162
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 26, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.